Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Anal Incontinence With Intersphincteric Implants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent.~2. Subject must be at least 18 years of age~3. Subject must have a St Marks score of at least 11~4. Subject must be able to comply with study and study follow-up requirements.~Exclusion Criteria:~1. Subjects with Crohn's disease or Ulcerative colitis~2. Subject has (a history of) malignancy in the rectum or anal canal~3. Subject has an ongoing treatment with chemotherapy (all indications)~4. Subject has verified active anal fistula(e)~5. Subject is unable or unwilling to provide informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intersphincteric implants (Type: EXPERIMENTAL): Treatment with intersphincteric implants in the anal sphincter using Sphinkeeper

Based on this trial design, predict the completion outcome and termination type (if applicable).